Indivior vs. Alvogen: Motion to Seal Confidential Information
Updated: 3 days ago
Indivior Inc., Indivior UK Limited, and Aquestive Therapeutics litigated patent issues against Alvogen, while Alvogen sought to seal portions of a hearing transcript containing confidential commercial information. The requested protection covered information concerning product development, research, business strategy, and other proprietary matters.
The District Court for the District of New Jersey granted the motion in part, concluding that specific proprietary material could be protected while less-sensitive or already-public information should remain accessible. The ruling illustrates the requirement for narrowly tailored sealing orders and the balance between public access to judicial records and legitimate competitive interests.
Comments